CATEGORY

APIs India

APIs produced in India - ANVISA, GMP and regulated suppliers

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike APIs India.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo
Meet Abi

The World’s first Digital Market Analyst

    Schedule a Demo
    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    APIs India Suppliers


    APIs India Supplier

    Find the right-fit apis india supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.

    Sample Supplier
    Company
    Catalent Inc.
    Location
    Jackson, Mississipi
    Duns number
    3862211

    D&B SER Rating

    dnb logo

    Up to 3 months

    1 9
    1
    Low Risk High Risk

    The Supplier Evaluation Risk (SER) Rating is Dun & Bradstreet’s proprietary scoring system used to assess the probability that a business will seek relief from creditors or cease operations within the next 12 months. SER ratings range from 1 to 9, with 9 indicating the highest risk of failure. We’ve prepared an infographic to help business owners better understand what influences their SER Rating.

    Moody`s ESG Solution
    ESG Profile

    Company and Sector Performance
    33

    100
    Limited (1)
    ESG Perfomance (/100)
    Environment
    30
    Social
    26
    Governance
    43
    6 Domains Performance (/100)
    Business behaviour
    34
    Human rights
    32
    Community Environment
    15
    Corporate governance
    56
    Human resources
    26
    Security Scorecard
    79

    Threat indicators
    A
    91
    Network Security
    Detecting insecure network settings
    A
    100
    Hacker Chatter
    Monitoring hacker sites for chatter about your company
    F
    52
    DNS Health
    Detecting DNS insecure configuration and vulnerabilities
    D
    62
    Application Security
    Detecting common website application vulnerbilities
    A
    100
    Endpoint Security
    Detecting unprotected enpoints or entry points of user tools, such as desktops, laptops mobile devices, and virtual desktops
    A
    100
    Cubic Score
    Proprietary algorithms checking for implementation of common security best practices
    A
    100
    Patching Cadence
    Out of date company assets which may contain vulnerabilities of risk
    A
    100
    Social Engineering
    Measuring company awareness to a social engineering or phising attack
    A
    90
    IP Reputation
    Detecting suspecious activity, such as malware or spam, within your company network
    A
    100
    Information Leak
    Potentially confidential company information which may have been inadvertently leaked

    Industry Comparison
    catalent.com
    Industry average
    Adverse Media Appearances
    Environmental Issues
    0
    Workforce Health Safety Issues
    0
    Product Service Issues
    0
    Human Rights Issues
    0
    Production Supply Chain Issues
    0
    Environmental Non Compliance Flags
    0
    Corruption Issues
    0
    Regulatory Non Compliance Flags
    0
    Fraud Issues
    0
    Labor Health Safety Flags
    0
    Regulatory Issues
    0
    Workforce Disputes
    0
    Sanctions
    0
    esg energy transition
    21
    Discrimination Workforce Rights Issues
    0
    esg controversies critical severity
    No

    APIs India market report transcript


    Regional Market Outlook on APIs in India

    Increasing pricing pressure and competition can be attributed to the dip in bulk drug and drug intermediates export from India in 2017 compared to previous years, where a continuous hike was witnessed in the export from India since 2013 until 2016.

    • The export of bulk drug and drug intermediates has decreased in the fiscal year 2016–2017 compared to 2015–2016, with a negative change rate of -5.47 percent
    • The fall in exports from India can be attributed to the increasing price burden and rapidly increasing competition from other countries, including China
    • Another reason contributing to the fall in exports of bulk drug is continuous investment of Indian companies in setting up their manufacturing plants in other countries in view of the global exposure, which is also contributing to the export drop
    • The export growth in the coming years is likely to be driven by fully operational USFDA facilities, thereby increasing the export to the US and other developed markets
    • Cost advantage is another factor, which might prove to be a contributing factor in the growth of API export from India in the coming years, as India's cost of production is almost 60 percent lower than that of the US and near to half of that of Europe

     

    Top Destinations for Indian API Export

    Key Takeaway: The US is the top export destination, followed by South Africa and Europe. Export to regulated markets was near to 80 percent and export to non-regulated market had decreased in the recent years 

    • The US is leading the charts, when it comes to the top destinations for Indian API export, followed by the UK, as it accounts for major chunk of the export taking place from India in various industries, pharmaceutical industry being one of th
    • For 2015–2016, export to regulated markets accounted 76.9 percent of the market share, whereas the export to non-regulated market was only 23 percent. For the next fiscal year, i.e. 2016–2017, there was a slight increment in export to regulated markets, with a market share of 77.47 percent, but there was a dip in the export to non-regulated market, with a share of 22.5 percent of the total exports for 2016–2017

    The Top APIs in Indian Market Based on Volume (tons)

    There are around 25 APIs, which are exported in volume of more than 500 tons, out of which Metformin is the one, which is exported in highest volume of about 16,000 tons. Paracetamol is the second highest exported API, with a volume of more than 13,000 tons. Some of the prominent manufacturers of Metformin includes Wanbury Limited and Harman Finochem Limited, and some top notch manufacturers of Paracetamol are Granules India Limited and Sri Krishna Pharmaceuticals Limited 

    The Top APIs in India Market Based on Value ($ million) 

    Cefuroxime has the highest export value of about $94 million, and it is manufactured on large scale by Aurobindo Pharma Limited and Nectar Lifesciences Limited. The second rank in value is grabbed by Omeprazole, which constitutes to around $85 million, and it is manufactured and exported majorly by Hetero Labs Limited and Cadila Healthcare Limited.